Try our beta test site
1 study found for:    22454421 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma
Condition: Disease, Hodgkin
Intervention: Drug: brentuximab vedotin

Study has passed its completion date and status has not been verified in more than two years.